Facility Evaluation Report

Licensing Program Analyst (LPA) Hanna Gough made an unannounced visit to the facility to conduct a Case Management visit in regards to an incident report that was submitted to the Regional Office on March 9, 2026. LPA was greeted and granted entry by staff. LPA met with Direct Support Professional (DSP) Eduardo Eleazar. DSP called Administrator (AD) Cora Kon and discussed the purpose of the visit with LPA.

LPA reviewed an incident report that stated that on March 2, 2026, Client #1 (C1) was in the hospital when testosterone vials and syringes were observed in C1s backpack.

LPA reviewed an ISP review report dated February 26, 2026, with C1 and C1s circle of support present where C1 addressed not taking the testosterone injections anymore, referring to a previous incident that occurred.

2 of 2 staff informed LPA that they have never seen the vials of testosterone or syringes in the facility or in C1s possession.

C1 informed LPA that they do not have any items at the facility.

LPA observed two boxes of empty disposable syringes in C1s bedroom that staff was unaware of.

Based on today's observations a deficiency is being noted per Title 22 Division 6 of the California Code of Regulations. An exit interview was conducted and a copy of this report was left at the facility along with LIC809D and appeal rights.